BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2883173)

  • 21. Use of anxiolytics in children.
    Siméon JG
    Encephale; 1993; 19(2):71-4. PubMed ID: 7903927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of withdrawal of buspirone and diazepam: a placebo controlled study.
    Fontaine R; Beaudry P; Beauclair L; Chouinard G
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):189-97. PubMed ID: 2888159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical profile of buspirone.
    Knapp JE
    Br J Clin Pract Suppl; 1985 May; 38():95-9. PubMed ID: 2862910
    [No Abstract]   [Full Text] [Related]  

  • 24. Sexual function and dysfunction in Brazilian patients with obsessive-compulsive disorder and social anxiety disorder.
    Fontenelle LF; de Souza WF; de Menezes GB; Mendlowicz MV; Miotto RR; Falcão R; Versiani M; Figueira IL
    J Nerv Ment Dis; 2007 Mar; 195(3):254-7. PubMed ID: 17468686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Buspirone: a non-benzodiazepine for anxiety.
    Med Lett Drugs Ther; 1986 Dec; 28(728):117-8. PubMed ID: 2878352
    [No Abstract]   [Full Text] [Related]  

  • 26. The safety and efficacy of ipsapirone vs. lorazepam in outpatients with generalized anxiety disorder (GAD): single site findings from a multicenter trial.
    Cutler NR; Sramek JJ; Wardle TS; Hesselink JM; Roeschen JK
    Psychopharmacol Bull; 1993; 29(2):303-8. PubMed ID: 7904761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonbenzodiazepine anxiolytics: clinical usefulness.
    Rickels K
    J Clin Psychiatry; 1983 Nov; 44(11 Pt 2):38-44. PubMed ID: 6139368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
    Cutler NR; Sramek JJ; Keppel Hesselink JM; Krol A; Roeschen J; Rickels K; Schweizer E
    J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Buspirone--a new antianxiety agent not chemically related to any presently marketed drugs [proceedings].
    Goldberg HL
    Psychopharmacol Bull; 1979 Apr; 15(2):90-2. PubMed ID: 34846
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of buspirone on panic disorder: a case report.
    Frazer GA; Lapierre YD
    J Clin Psychopharmacol; 1987 Apr; 7(2):118-9. PubMed ID: 2884236
    [No Abstract]   [Full Text] [Related]  

  • 31. Psychopharmacologic treatment of anxiety.
    Altesman RI; Cole JO
    J Clin Psychiatry; 1983 Aug; 44(8 Pt 2):12-8. PubMed ID: 6135691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of the 5-HT1A agonist, buspirone hydrochloride, in migraineurs with anxiety: a randomized, prospective, parallel group, double-blind, placebo-controlled study.
    Lee ST; Park JH; Kim M
    Headache; 2005 Sep; 45(8):1004-11. PubMed ID: 16109114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of buspirone and diazepam in generalized anxiety disorder.
    Jacobson AF; Dominguez RA; Goldstein BJ; Steinbook RM
    Pharmacotherapy; 1985; 5(5):290-6. PubMed ID: 2866493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sexual functioning associated with quetiapine switch vs. risperidone continuation in outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind pilot trial.
    Byerly MJ; Nakonezny PA; Rush AJ
    Psychiatry Res; 2008 May; 159(1-2):115-20. PubMed ID: 18295343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gepirone and the treatment of panic disorder: an open study.
    Pecknold JC; Luthe L; Scott-Fleury MH; Jenkins S
    J Clin Psychopharmacol; 1993 Apr; 13(2):145-9. PubMed ID: 8096526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Venlafaxine extended release (XR) in the treatment of generalized anxiety disorder.
    Sheehan DV
    J Clin Psychiatry; 1999; 60 Suppl 22():23-8. PubMed ID: 10634352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meta-analysis of the safety and tolerability of two dose regimens of buspirone in patients with persistent anxiety.
    Sramek JJ; Hong WW; Hamid S; Nape B; Cutler NR
    Depress Anxiety; 1999; 9(3):131-4. PubMed ID: 10356651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Buspirone hydrochloride in the treatment of transvestic fetishism.
    Fedoroff JP
    J Clin Psychiatry; 1988 Oct; 49(10):408-9. PubMed ID: 3271001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alprazolam in clinically anxious patients with depressed mood.
    Aden GC
    J Clin Psychiatry; 1983 Jan; 44(1):22-4. PubMed ID: 6130082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Female sexual dysfunction associated with antidepressant administration: a randomized, placebo-controlled study of pharmacologic intervention.
    Michelson D; Bancroft J; Targum S; Kim Y; Tepner R
    Am J Psychiatry; 2000 Feb; 157(2):239-43. PubMed ID: 10671393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.